Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04260958
Other study ID # U-2018-312
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 3, 2020
Est. completion date June 1, 2028

Study information

Verified date July 2023
Source Sahlgrenska University Hospital, Sweden
Contact Maria Back, Ass Prof
Phone +46700895612
Email maria.m.back@vgregion.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall aim of the study is to evaluate if remote video exercise-based cardiac rehabilitation (exCR), offered as an alternative to centre-based exCR, can increase participation in exCR sessions post myocardial infarction (MI).


Description:

Due to the covid-19 pandemic, this study will be performed in two steps: 1). National feasibility and safety study. 2). National multicenter registry-based cluster randomized crossover clinical trial (RRCT). 1. In the feasibility study, patients will be offered remote exCR at all participating sites until the peak of the pandemic has been achieved and care goes back to normal. The feasibility study will include patients until Aug 2022. 2. CR centers (not patients) will be cluster randomized to either the intervention or control. Patients at intervention centers will be offered remote exCR, usual care centre-based exCR, or a combination of both modes, as self-preferred choice. At control centers, patients will be offered usual care centre-based exCR only. The duration of each time period for each center will be 15 months. Long-term follow-up will be performed 1 year and 3 years after the index cardiac event.


Recruitment information / eligibility

Status Recruiting
Enrollment 1500
Est. completion date June 1, 2028
Est. primary completion date June 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 79 Years
Eligibility Inclusion Criteria: - Written informed consent - Diagnosis of type 1 myocardial infarction (AMI) - Age 18-79 years at discharge from hospital Exclusion Criteria: - Patients with incomplete coronary revascularization defined as at least one remaining hemodynamically significant stenosis - Severe valve or structural heart disease - Severe heart failure (NYHA III - IV) - Serious arrythmias - Inability to understand Swedish - No internet access at home (only applicable for patients in the intervention group who wants to perform remote exCR) - Pathological exercise test indicating high risk for adverse events during exCR - More than 6 months between discharge form hospital and screening - Any other condition that may interfere with the possibility for the patient to comply with the study protocol

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exercise-based cardiac rehabilitation
The exercise program (remote/centre-based) will be standardized. An exCR-program is defined as at least 24 supervised sessions, with a total session length of 60 minutes, for at least 3 months, with possibility to complete missed sessions the 4th month. Each exercise session includes at least 20 min of aerobic exercise, intensity 13-17 on Borg´s rating of perceived exertion (RPE)-scale ˜ 60% - 85% of VO2max or 70 - 95% of maximal heart rate. In addition, each exercise session includes 1-3 sets of 8-10 upper and/or lower limb exercises in 10-15 repetitions, 40-80% of 1 repetition maximum. Attending =75% of the 24 sessions over a 4-month period will be considered as successful.

Locations

Country Name City State
Sweden Södra Älvsborg Hospital Borås
Sweden Mälarsjukhuset Eskilstuna
Sweden Falun hospital Falun
Sweden Gällivare Hospital Gällivare
Sweden Gävle Hospital Gävle
Sweden Angered Hospital Gothenburg
Sweden Sahlgrenska University Hospital Gothenburg
Sweden Sahlgrenska University Hospital Östra Gothenburg
Sweden Hässleholm Hospital Hässleholm
Sweden Jönköping Ryhov hospital Jönköping
Sweden Kalix hospital Kalix
Sweden Kalmar Hospital Kalmar
Sweden Kungälv Hospital Kungälv
Sweden Lindesberg Hospital Lindesberg
Sweden Linköping University Hospital Linköping
Sweden Ljungby Hospital Ljungby
Sweden Sunderbyn hospital Luleå
Sweden Skåne University hospital Lund
Sweden Skåne University Hospital Malmö Malmö
Sweden Östersund hospital Östersund
Sweden Södertälje Hospital Södertälje
Sweden Capio St Göran Hospital Stockholm
Sweden Karolinska University Hospital Stockholm
Sweden Sundsvall hospital Sundsvall
Sweden Uppsala University Hopsital Uppsala
Sweden Värnamo hospital Värnamo

Sponsors (4)

Lead Sponsor Collaborator
Sahlgrenska University Hospital, Sweden Göteborg University, Linkoeping University, Uppsala University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean number of exCR sessions The primary outcome is the mean number of EBCR sessions (center based or remote) during 0-4 months (from start of the EBCR program) for patients at a center during each randomization period. Eligible patients that have not started the EBCR program within 6 months of screening will be counted as 0 sessions. Attending =75% of the 24 recommended sessions over a 4-month period will be considered as completion, and proportion completers will be presented in a supportive responder analysis. 3-4 months
Secondary Submaximal exercise capacity Bicycle ergometer test according to the WHO-protocol with an increased workload of 25W every 4.5 minutes. The exercise test is discontinued at Borg RPE 17 and/or dyspnea 7 at Borg´s CR-10 scale. 3-4 months
Secondary Muscular endurance tests Unilateral isotonic shoulder flexion (maximum number of repetitions) and a unilateral isotonic heel lift (maximum number of repetitions) 3-4 months
Secondary Self-reported physical activity and exercise Two questions on physical activity and exercise during the latest week according to Haskell´s questionnaire (Min:0, Max:7). Ordinal scale, number of days. 3-4 months
Secondary Self-reported physical activity and exercise Haskell Haskell´s questionnaire (Min:0, Max:7). A high score means higher level of physical activity and exercise. 3-4 months
Secondary Self-reported physical capacity Visual analog scale, (100=best possible physical capacity, 0=worst possible physical capacity), a dichotomous question: Do you experience any limitation in everyday life due to your current physical capacity? (yes vs no). If yes: multiple choice on reasons 3-4 months
Secondary Health-related quality of life EQ5D Euro Quality of Life (EQ-5D 3L). The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results into a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state. A high score indicates better Health. 3-4 months
Secondary Health-related quality of life VAS Euro Quality of Life VAS. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale where the endpoints are labelled 'Best imaginable health state'(100) and 'Worst imaginable health state' (0) 3-4 months
Secondary Kinesiophobia (fear of movement) Tampa Scale for Kinesiophobia Heart (17 items, ordinal scale 1-4) 1, strongly disagree, 4, strongly agree. A higher score is means higher values of kinesiophobia (worse). 3-4 months
Secondary Self-efficacy for Exercise Scale Self-efficacy for Exercise Scale. 9 items, ordinal scale. 0=not Confident, 10=very Confident. Total score is calculated by summing the responses to each question. This scale has a range of total scores from 0-90. A higher score indicates higher self-efficacy for exercise 3-4 months
Secondary Self-reported perceptions on exercise Patient´s perceptions of remote exCR or centre-based exCR. 1, strongly disagree, 4, strongly agree. This questionnarie is designed by the authors. High score, better outcome. 3-4 months
Secondary Cost-effectiveness A cost-effectiveness analysis will be performed in order to estimate the cost per quality-adjusted life-year (QALY) associated with the intervention compared with control. Healthcare costs associated with investigated treatments will be assessed by extracting resource use from the relevant registries, and QALYs will be determined by combining survival status and the quality-of-life measurements provided by the EQ-5D-3L instrument. End of study
Secondary Socio-economic evaluation Data from Statistics Sweden will be used to evaluate study results in relation to socio-economic data 6 years
Secondary Number of Cardiovascular events All-cause mortality, cardiovascular mortality, recurrent hospitalization for ACS, heart failure hospitalization, stroke and repeat coronary revascularization, reported in SWEDEHEART, the National Patient Registry and the Cause of Death Register will be performed. 1 and 3 years after the last patient visit
See also
  Status Clinical Trial Phase
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Completed NCT04507529 - Peer-mentor Support for Older Vulnerable Myocardial Infarction Patients N/A
Recruiting NCT06066970 - Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
Recruiting NCT03620266 - Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI N/A
Completed NCT04097912 - Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
Completed NCT04153006 - Comparison of Fingerstick Versus Venous Sample for Troponin I.
Completed NCT03668587 - Feasibility and Security of a Rapid Rule-out and rule-in Troponin Protocol in the Management of NSTEMI in an Emergency Departement
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Completed NCT03076801 - Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease? N/A
Recruiting NCT05371470 - Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation N/A
Recruiting NCT04562272 - Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP N/A
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT06007950 - Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health N/A
Withdrawn NCT05327855 - Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI) Phase 2
Recruiting NCT02876952 - High Intensity Aerobic Interval Training With Mediterranean Diet Recommendations in Post-Myocardial Infarct Patients N/A
Completed NCT02917213 - Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
Completed NCT02711631 - Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation N/A
Completed NCT02305602 - A Study of VentriGel in Post-MI Patients Phase 1
Completed NCT02552407 - Thrombectomy in ST Elevation Myocardial Infarction, an Individual Patient Meta-analysis N/A